← Leaderboards
Michael Joseph Peluso
University Of California, San Francisco
$3,279,692
Attributed
$5,152,865
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,152,865 · 3
AHRQ$2,000,000 · 1
By mechanism
R01$2,225,597 · 2
U18$2,000,000 · 1
K23$927,268 · 1
Top collaborators
- Vivek Jain2 shared
- Lekshmi Santhosh2 shared
- Edwin Duncan Charlebois1 shared
- Nadia R Roan1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Alka M Kanaya$23,487,726
- Margot B Kushel$15,430,352
- Scarlett L Gomez$14,448,454
- Glenn-Milo Santos$8,436,377
- Jeremy David Keenan$19,787,326
Others in their field
Other Emerging Leaders on “Blood”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
BloodCohortInflammationImmune System DiseasesProspectiveProgramsVirusBiopsyInflammatoryTissuesProspective StudiesFundingSamplingPersonsMagnetic Resonance ImagingLaboratoriesCross-Sectional StudiesImageChronicAdaptive Immune ResponsePhenotypeCharacteristicsExhibitsInterest
Grant awards (10)
Broadening the scale and impact of a comprehensive Long COVID clinic to serve diverse patient groups with multidisciplinary care and research access$1,000,000
U18 · FY2025 · HS
Assessing the mechanisms underlying female sex-predominance in Long COVID$913,012
R01 · FY2025 · AI · contact PI
Evaluating SARS-CoV-2 spike antigen-induced coagulopathy and neuroinflammation as mechanistic drivers of neurologic PASC$647,609
R01 · FY2025 · NS · contact PI
Characterizing the virologic and immunologic signatures of HIV exceptional control$161,909
K23 · FY2025 · AI · contact PI
Broadening the scale and impact of a comprehensive Long COVID clinic to serve diverse patient groups with multidisciplinary care and research access$1,000,000
U18 · FY2024 · HS
Evaluating SARS-CoV-2 spike antigen-induced coagulopathy and neuroinflammation as mechanistic drivers of neurologic PASC$664,976
R01 · FY2024 · NS · contact PI
Characterizing the virologic and immunologic signatures of HIV exceptional control$161,909
K23 · FY2024 · AI · contact PI
Characterizing the virologic and immunologic signatures of HIV exceptional control$201,150
K23 · FY2023 · AI · contact PI
Characterizing the virologic and immunologic signatures of HIV exceptional control$201,150
K23 · FY2022 · AI · contact PI
Characterizing the virologic and immunologic signatures of HIV exceptional control$201,150
K23 · FY2021 · AI · contact PI